Related references
Note: Only part of the references are listed.Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly
Felix Stader et al.
CLINICAL PHARMACOKINETICS (2020)
Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease
Anna Vildhede et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Antenatal and Postnatal Analgesia: Scientific Impact Paper No. 59
D. L. Bisson et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2019)
Use of Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Axitinib Exposure: A Fresh Approach to Precision Dosing in Oncology
Michael J. Sorich et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation
Thomas M. Polasek et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published Models
Andre Dallmann et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective
Mohamad Shebley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Drug Exposure
Andrew Rowland et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Model-Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities
Ron J. Keizer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review
Jennifer N. Lind et al.
PEDIATRICS (2017)
Role of pharmacokinetic modeling and simulation in precision dosing of anticancer drugs
Adam S. Darwich et al.
TRANSLATIONAL CANCER RESEARCH (2017)
Transcriptional Regulation of CYP2D6 Expression
Xian Pan et al.
DRUG METABOLISM AND DISPOSITION (2017)
Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations
Vamshi Krishna Jogiraju et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2017)
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future
A. S. Darwich et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter
C. Emoto et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Physiological changes in pregnancy
Priya Soma-Pillay et al.
CARDIOVASCULAR JOURNAL OF AFRICA (2016)
Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease
Roseann S. Gammal et al.
PEDIATRICS (2016)
Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and In silico Assessment of Metabolic Drug-Drug Interactions Involving Modafinil
Angela Rowland et al.
FRONTIERS IN PHARMACOLOGY (2016)
Pharmacokinetics of drugs in pregnancy
Maisa Feghali et al.
SEMINARS IN PERINATOLOGY (2015)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
K. R. Crews et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Applications of CYP450 Testing in the Clinical Setting
C. F. Samer et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women
Alice Ban Ke et al.
DRUG METABOLISM AND DISPOSITION (2013)
A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4
Lu Gaohua et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Pharmacogenomics of Codeine, Morphine, and Morphine-6-Glucuronide Model-Based Analysis of the Influence of CYP2D6 Activity, UGT2B7 Activity, Renal Impairment, and CYP3A4 Inhibition
Thomas Eissing et al.
MOLECULAR DIAGNOSIS & THERAPY (2012)
Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review
P. Zhao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Effects of codeine on pregnancy outcome: results from a large population-based cohort study
Katerina Nezvalova-Henriksen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
CYP2D6 Polymorphisms and Codeine Analgesia in Postpartum Pain Management: A Pilot Study
Sondra vanderVaart et al.
THERAPEUTIC DRUG MONITORING (2011)
Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut-The effect of diltiazem on the time-course of exposure to triazolam
Karen Rowland Yeo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
In Vitro-In Vivo Extrapolation Predicts Drug-Drug Interactions Arising from Inhibition of Codeine Glucuronidation by Dextropropoxyphene, Fluconazole, Ketoconazole, and Methadone in Humans
Pritsana Raungrut et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part II
Shu-Feng Zhou
CLINICAL PHARMACOKINETICS (2009)
Developmental changes in human liver CYP2D6 expression
Jeffrey C. Stevens et al.
DRUG METABOLISM AND DISPOSITION (2008)
Fetal morphine metabolism and clearance are constant during late gestation
M Garland et al.
DRUG METABOLISM AND DISPOSITION (2006)
Neonatal signs after late in utero exposure to serotonin reuptake inhibitors - Literature review and implications for clinical applications
EL Moses-Kolko et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy
TS Tracy et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Codeine intoxication associated with ultrarapid CYP2D6 metabolism
Y Gasche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication
I Cascorbi
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Isoform selectivity and kinetics of morphine 3-and 6-glucuronidation by human UDP-glucuronosyltransferases: Evidence for atypical glucuronidation kinetics by UGT2B7
AN Stone et al.
DRUG METABOLISM AND DISPOSITION (2003)
Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes:: Specificity and influence of the UGT2B7*2 polymorphism
MH Court et al.
DRUG METABOLISM AND DISPOSITION (2003)
Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships
WH Chou et al.
CLINICAL CHEMISTRY (2003)
Codeine ingestion and apparent life-threatening event in a neonate
TF Tong et al.
PEDIATRICS INTERNATIONAL (2001)
Share Paper
